Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
I PREVENT - Irbesartan In Hypertensive Diabetic Patients
- Conditions
- Hypertension
- First Posted Date
- 2006-08-09
- Last Posted Date
- 2011-04-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 797
- Registration Number
- NCT00362258
- Locations
- 🇪🇬
Sanofi-Aventis Administrative Office, Cairo, Egypt
Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2006-08-08
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 317
- Registration Number
- NCT00361738
- Locations
- 🇿🇦
Sanofi-Aventis Administrative Office, Midrand, South Africa
An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder
- Conditions
- Depressive Disorder
- First Posted Date
- 2006-08-08
- Last Posted Date
- 2009-01-16
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 324
- Registration Number
- NCT00361491
- Locations
- 🇷🇺
Sanofi-Aventis Administrative Office, Moscow, Russian Federation
Insulin Glulisine in Type 2 Diabetic Patients
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2006-08-07
- Last Posted Date
- 2011-08-08
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 106
- Registration Number
- NCT00360698
- Locations
- 🇷🇺
Sanofi-Aventis, Moscow, Russian Federation
🇬🇧Sanofi-aventis, Guildford, United Kingdom
ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"
- Conditions
- Ischemia
- First Posted Date
- 2006-08-04
- Last Posted Date
- 2010-08-31
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 110
- Registration Number
- NCT00360386
Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2016-05-24
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 501
- Registration Number
- NCT00359437
- Locations
- 🇬🇧
Sanofi-Aventis Administrative Office, Guildford Surrey, United Kingdom
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 463
- Registration Number
- NCT00358878
- Locations
- 🇬🇧
Sanofi-Aventis Administrative Office, Guildford, Surrey, United Kingdom
An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder
- Conditions
- Depressive Disorder
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2009-04-13
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 319
- Registration Number
- NCT00358631
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States
Stilnox Treatment in Elderly Patients With Insomnia
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 115
- Registration Number
- NCT00359229
Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 220
- Registration Number
- NCT00358124
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States